Clinical Trial Update: ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating ABT-378 (lopinavir) boosted with ritonavir plus reverse transcriptase inhibitors in antiretroviral-naive HIV-infected subjects. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lopinavir (lopinavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Abbott | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED